Pyrvinium pamoate.
D000284:Administration, Oral; D002986:Clinical Trials as Topic; D006801:Humans; D010123:Oxyuriasis / Q000188:drug therapy*; D010316:Particle Size; D011774:Pyrvinium Compounds / Q000008:administration & dosage* / Q000009:adverse effects / Q000032:analysis / Q000627:therapeutic use / Q000652:urine; D013050:Spectrometry, Fluorescence; D013535:Suspensions; D013607:Tablets; D013810:Therapeutic Equivalency; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
D011774:Pyrvinium Compounds; D013535:Suspensions; D013607:Tablets